Since 2016, the iShares U.S. Aerospace & Defense exchange-traded fund (ITA) has risen by over 60%. Geopolitical uncertainty, alongside a massive increase in military spending have been good news for defense stocks.
According to Buckingham Research Group analyst Richard Safran, the rally is set to continue in 2021. The analyst believes the fear of a possible left-leaning presidency’s negative impact on the sector is exaggerated. He said, “Although the 2020 elections remain an overhang on Defense stocks, we think the risks are way overstated and have hampered Defense multiples from expanding despite continued end-market growth.”
Investment bank Morgan Stanley recently reviewed the defense sector stocks under its coverage, we lined up 2 of the tickers alongside each other to get the lowdown. The word on the Street is that the outlook appears rosy for these two. Let’s take a closer look.
L3Harris Technologies (LHX)
One of 2019’s success stories, L3Harris is in fact a new company – the result of a merger between L3 Technologies and Harris Corporation. The company’s share price appreciated by 46.95% in 2019, and 2020 has continued in much the same vein. It is up by over 12% year-to-date.
The company provides various products and services to the defense industry, including C6ISR systems, wireless equipment, tactical radios, avionics and night vision equipment, amongst others. The merger has significantly bolstered L3Harris’s proposition, as it took two midsize defense companies and created a larger beast capable of competing for large Pentagon contracts that, otherwise, would have been out of reach for both.
Alongside the merger, 2019’s market beating performance was instigated by a series of estimate beating reports and strong sales growth. So, now that L3Harris is no longer trading at such a bargain price, does it remain a tantalizing proposition in 2020?
It does, according to Morgan Stanley’s Matthew Sharpe. Sharpe thinks “LHX remains a peer leader on topline growth”.
Sharpe noted, “Post the LLL-HRS merger, we believe LHX sets itself up as a leading Defense Prime with wide ranging capabilities from radios to small satellites. Given above-average potential around sales growth, margin expansion, FCF generation, and capital returns, alongside a leadership team that has previously executed, we see no reason why the legacy HRS premium valuation should not be retained (at 5-6% FCF versus 2021 at ~7%).”
Bottom line, then? Sharpe keeps his Overweight rating along with the price target of $259. This conveys the analyst’s confidence L3Harris can add a further 16.5% to the share price over the coming months.
The Street is on the bullish side, too. 7 Buys and a single Hold coalesce into a Strong Buy consensus rating. The average price target comes in at $227.86 and indicates possible gains of 13.5%.
With annual revenue of more than $30 billion, global aerospace and defense technology company Northrop Grumman is one of the world’s largest weapons manufacturers. Like L3Harris, Northrop outperformed the market last year, adding 43% to its share price along the way. It has kept up the pace in 2020, too; the heightened tension between the US and Iran, and the fear of a looming war have been good news for the company.
As befits a multinational the size of Northrop, the company is involved in large scale development programs; Northrop is currently developing the B-21 Raider, a long-range strategic bomber which will replace its own B-2 Spirit, the world’s only known stealth bomber. The company is also involved in NASA’s Space Launch System program, for which it is producing the solid rocket boosters.
Additionally, in December 2019, following Boeing’s removal of its bid for the coveted GBSD (Ground Based Strategic Deterrent) contract, Nothrop remains the sole bidder for the development of the intercontinental ballistic missile system, worth a purported $63 billion.
Following 2019’s consistent execution, in which the company beat earnings estimates in all 4 calendar reports, Sharpe expects the upcoming report to show “improved revenue growth relative to prior quarters”. The analyst predicts expansion of 9% year-over-year to $8.9 billion.
Sharpe added, “We believe NOC is well positioned given its longer duration capability and high-end technology focus, that is well aligned to the NDS, including the Prime position on B-21 ($50B+), pursuit of GBSD (~$85B), and acquisition of Orbital ATK (~$9B) for space. As such, inﬂecting revenue and margin potential, along with portfolio shaping opportunities (via Technology Services), and an easing investment cycle support an attractive FCF yield come 2021 at ~7%.”
Sharpe, then, reiterates an Overweight rating on the weapons manufacturer, alongside a $449 price target. The figure implies further upside potential of 28.5%.
Looking at the consensus breakdown, it appears the bulls have it. With 4 Buys and a single Hold, the word on the Street is that NOC is a Strong Buy. At $425.80, the average price target presents possible upside in the shape of 22.33%.
Article partially appeared on smarteranalyst.com
* The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained on our Site constitutes a solicitation, recommendation, endorsement, or offer by De Angelis & Associates or any third party service provider to buy or sell any securities or other financial instruments in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All Content on this site is information of a general nature and does not address the circumstances of any particular individual or entity.
Credit: Morgan Stanley, NYSE
© De Angelis & Associates 2020. All Rights Reserved.